You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Comparison of the MTBDRplus assay with conventional drug susceptibility testing at onset and 5th month

From: Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplusassay and their implication for treatment outcomes in patients from Mumbai, India

   GENOTYPIC DST
PHENOTYPIC DST   INHs RIFs INHr RIFs INHs RIFr INHr RIFr
Onset (n = 88) INHs RIFs 43 7 0 0
  INHr RIFs 2 13 0 3
  INHs RIFr 0 0 1 1
  INHr RIFr 1 0 1 16
5th month (n = 67) INHs RIFs 1 0 0 0
  INHr RIFs 0 2 0 1
  INHs RIFr 0 0 1 2
  INHr RIFr 0 0 1 59